NCT02647489View on ClinicalTrials.gov

Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2017

Conditions
Malaria, Antepartum
Interventions
BIOLOGICAL

PAMVAC

BIOLOGICAL

Alhydrogel

BIOLOGICAL

GLA-SE

BIOLOGICAL

GLA-LSQ

OTHER

Placebo

Trial Locations (1)

Unknown

Institut de Recherche Clinique du Benin (IRCB), Abomey-Calavi

Sponsors
All Listed Sponsors
collaborator

University of Copenhagen

OTHER

collaborator

Université d'Abomey-Calavi

OTHER

collaborator

European Vaccine Initiative

OTHER

collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

collaborator

ExpreS2ion Biotechnologies

INDUSTRY

lead

University Hospital Tuebingen

OTHER